Scarica l'app Stockscreener
7.54
2.86%
0.21
Dopo l'orario di chiusura:
7.61
0.07
+0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$7.33
Aprire:
$7.33
Volume 24 ore:
357.49K
Relative Volume:
1.37
Capitalizzazione di mercato:
$197.62M
Reddito:
$47.26M
Utile/perdita netta:
$-58.48M
Rapporto P/E:
-2.7875
EPS:
-2.7049
Flusso di cassa netto:
$-40.45M
1 W Prestazione:
+34.88%
1M Prestazione:
+1.62%
6M Prestazione:
-9.59%
1 anno Prestazione:
-54.50%
Intervallo 1D:
$6.96
$7.60
Intervallo di 1 settimana:
$5.575
$7.84
Portata 52W:
$4.2993
$17.78
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Confronta CVRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.54 | 192.12M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Reiterato | Lake Street | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Lake Street | Buy |
| 2022-07-18 | Iniziato | Craig Hallum | Buy |
| 2021-07-26 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-26 | Iniziato | Piper Sandler | Overweight |
| 2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
CVRx supports MU Health with first Barostim implant - Traders Union
The Truth About CVRx Inc: Wall Street’s Sleeping Giant You’re Not Watching (Yet) - AD HOC NEWS
CVRx Kicks Off One Of The Largest Heart Device Trials In History - Sahm
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX) - The Globe and Mail
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途资讯
CVRx’s stock up as heart failure device to be trialled in expanded patient group - Yahoo Finance
CVRx launches major heart failure trial to expand Barostim therapy reach - Investing.com Australia
CVRx Initiates BENEFIT-HF Trial; Q4 Financial Report Coming Soon - RTTNews
Cvrx Announces Initiation Of Benefit-Hf, A Landmark Heart Failure Trial - TradingView
CVRx stock rises after announcing major heart failure clinical trial By Investing.com - Investing.com South Africa
CVRx stock rises after announcing major heart failure clinical trial - Investing.com
New heart implant trial could triple patients eligible for Barostim - Stock Titan
Activity Recap: Does Amarin Corporation plc Depositary Receipt have declining or rising EPSWall Street Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
The Technical Signals Behind (CVRX) That Institutions Follow - Stock Traders Daily
Movement Recap: Whats the beta of CVRx Inc stock2025 Key Highlights & Expert Approved Momentum Ideas - baoquankhu1.vn
Fundamentals Check: Whats the beta of CVRx Inc stockBuy Signal & Smart Money Movement Tracker - baoquankhu1.vn
AI Stocks: What is the earnings history of CVRx IncQuarterly Market Review & AI Forecasted Stock Moves - baoquankhu1.vn
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Aug PostEarnings: Does Tootsie Roll Industries Inc have consistent dividend growthStock Surge & Detailed Earnings Play Alerts - baoquankhu1.vn
Aug Setups: Why is CVRx Inc stock going downQuarterly Portfolio Summary & Verified Technical Trade Signals - baoquankhu1.vn
Bull Bear: Should value investors consider CVRXJuly 2025 Recap & AI Driven Price Predictions - baoquankhu1.vn
Sentiment Review: Is LKQ Corporation stock a good pick for beginners2025 Market Overview & High Accuracy Swing Trade Signals - baoquankhu1.vn
CVRx reports patient life transformation with Barostim - Traders Union
$CVRX stock is down 14% today. Here's what we see in our data. - Quiver Quantitative
Wolf Popper LLP Announces Investigation on Behalf of CVRx, Inc. Investors - GlobeNewswire
CVRx expects 11-18% revenue growth in 2026 following CPT code transition - Investing.com Nigeria
Chart Watch: Will CVRX stock deliver long term returnsJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Bộ Nội Vụ
CVRx Establishes At-The-Market Equity Offering Program - The Globe and Mail
CVRx (NASDAQ:CVRX) Stock Price Down 9.9%Here's What Happened - MarketBeat
CVRx (NASDAQ:CVRX) Stock Price Down 9.9% – Here’s What Happened - Defense World
Does CVRx Inc meet Warren Buffetts criteria2025 Breakouts & Breakdowns & High Conviction Buy Zone Picks - baoquankhu1.vn
CVRx reports preliminary 2025 results, issues 2026 guidance - MSN
CVRx Issues 2026 Outlook and Expands Loan Facility - The Globe and Mail
Cvrx reports preliminary fourth quarter and fiscal year 2025 financial results and issues fiscal 2026 guidance - marketscreener.com
Cvrx Incon Jan 9, amends existing loan and security agreement dated Oct 31 2022SEC filing - marketscreener.com
CVRx Signs Loan Agreement Amendment With Innovatus Life Sciences Fund I - TradingView — Track All Markets
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance - GlobeNewswire
Precision Trading with Cvrx Inc. (CVRX) Risk Zones - Stock Traders Daily
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Will CVRx Inc. stock recover faster than marketDip Buying & High Accuracy Investment Signals - ulpravda.ru
Is CVRx Inc. stock a top momentum playEarnings Recap Summary & Weekly High Potential Stock Alerts - ulpravda.ru
Why CVRx Inc. stock is a must watch in 20252025 Dividend Review & Technical Entry and Exit Tips - Улправда
Dividend Watch: Can CVRX stock resist market sell offsQuarterly Profit Review & AI Driven Price Forecasts - Улправда
CVRx: Clinical innovation boosts heart failure care - Traders Union
Aug Spikes: Can CVRX stock beat market expectations this quarterPortfolio Profit Report & Daily Profit Maximizing Tips - moha.gov.vn
CVRx’s Barostim therapy receives Category I CPT codes By Investing.com - Investing.com India
Cvrx announces implementation of new category I CPT codes for Barostim therapy - marketscreener.com
CVRx’s Barostim therapy receives Category I CPT codes - Investing.com
CVRx announces implementation of new category I CPT codes for Barostim therapy - TipRanks
CVRx, Inc. Announces Transition to Category I CPT Codes for Barostim Therapy Effective January 1, 2026 - Quiver Quantitative
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):